Orbimed Advisors LLC, 10% Owner at PMV Pharmaceuticals, Inc. (PMVP), sold 500,000 shares at $1.80 ($900K) on 2025-09-10, disclosed to the SEC on 2025-09-12.
Open-market sale of $900k PMVP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BRVE | BUY | 2026-08-11 | $34.9M | — | Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-09 | $3.9M | — | Filing → |